198 related articles for article (PubMed ID: 23295150)
21. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells.
Rosová I; Dao M; Capoccia B; Link D; Nolta JA
Stem Cells; 2008 Aug; 26(8):2173-82. PubMed ID: 18511601
[TBL] [Abstract][Full Text] [Related]
22. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
[TBL] [Abstract][Full Text] [Related]
23. [Role of RhoA in hypoxia-induced breast cancer cell VEGF secretion and proliferation, migration and tube formation of HUVECs].
Ma J; Zhao Q; Ren H; Liu W; Xue Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):784-8. PubMed ID: 22699054
[TBL] [Abstract][Full Text] [Related]
24. Human mesenchymal stem cells promote cancer motility and cytokine secretion in vitro.
Scherzed A; Hackenberg S; Radeloff A; Froelich K; Rak K; Hagen R; Kleinsasser N
Cells Tissues Organs; 2013; 198(5):327-37. PubMed ID: 24356396
[TBL] [Abstract][Full Text] [Related]
25. [Effects of hypoxia-pretreated rat adipose-derived mesenchymal stem cells conditioned medium on wound healing of rats with full-thickness defects].
Gao M; Zhang J; Wang JZ; Liu Y; Zhang X; Shi Y
Zhonghua Shao Shang Za Zhi; 2020 Sep; 36(9):803-812. PubMed ID: 32972065
[No Abstract] [Full Text] [Related]
26. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential.
Valorani MG; Germani A; Otto WR; Harper L; Biddle A; Khoo CP; Lin WR; Hawa MI; Tropel P; Patrizi MP; Pozzilli P; Alison MR
Cell Tissue Res; 2010 Jul; 341(1):111-20. PubMed ID: 20496083
[TBL] [Abstract][Full Text] [Related]
28. Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro.
Burlacu A; Grigorescu G; Rosca AM; Preda MB; Simionescu M
Stem Cells Dev; 2013 Feb; 22(4):643-53. PubMed ID: 22947186
[TBL] [Abstract][Full Text] [Related]
29. Replicative senescence in MSCWJ-1 human umbilical cord mesenchymal stem cells is marked by characteristic changes in motility, cytoskeletal organization, and RhoA localization.
Bobkov D; Polyanskaya A; Musorina A; Lomert E; Shabelnikov S; Poljanskaya G
Mol Biol Rep; 2020 May; 47(5):3867-3883. PubMed ID: 32372170
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro.
Potapova IA; Gaudette GR; Brink PR; Robinson RB; Rosen MR; Cohen IS; Doronin SV
Stem Cells; 2007 Jul; 25(7):1761-8. PubMed ID: 17395769
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.
Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB
Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074
[TBL] [Abstract][Full Text] [Related]
32. TAFA2 Induces Skeletal (Stromal) Stem Cell Migration Through Activation of Rac1-p38 Signaling.
Jafari A; Isa A; Chen L; Ditzel N; Zaher W; Harkness L; Johnsen HE; Abdallah BM; Clausen C; Kassem M
Stem Cells; 2019 Mar; 37(3):407-416. PubMed ID: 30485583
[TBL] [Abstract][Full Text] [Related]
33. The balance between proliferation and transcription of angiogenic factors of mesenchymal stem cells in hypoxia.
Buizer AT; Bulstra SK; Veldhuizen AG; Kuijer R
Connect Tissue Res; 2018 Jan; 59(1):12-20. PubMed ID: 28165799
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses.
Tomchuck SL; Zwezdaryk KJ; Coffelt SB; Waterman RS; Danka ES; Scandurro AB
Stem Cells; 2008 Jan; 26(1):99-107. PubMed ID: 17916800
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
[TBL] [Abstract][Full Text] [Related]
36. Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1α, FASN, and mTORC1.
Lee HJ; Ryu JM; Jung YH; Oh SY; Lee SJ; Han HJ
Stem Cells; 2015 Jul; 33(7):2182-95. PubMed ID: 25825864
[TBL] [Abstract][Full Text] [Related]
37. Migrational changes of mesenchymal stem cells in response to cytokines, growth factors, hypoxia, and aging.
Naaldijk Y; Johnson AA; Ishak S; Meisel HJ; Hohaus C; Stolzing A
Exp Cell Res; 2015 Oct; 338(1):97-104. PubMed ID: 26335540
[TBL] [Abstract][Full Text] [Related]
38. Macrophage migration inhibitory factor regulates AKT signaling in hypoxic culture to modulate senescence of human mesenchymal stem cells.
Palumbo S; Tsai TL; Li WJ
Stem Cells Dev; 2014 Apr; 23(8):852-65. PubMed ID: 24274936
[TBL] [Abstract][Full Text] [Related]
39. The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro.
Zhao L; Xu G; Zhou J; Xing H; Wang S; Wu M; Lu YP; Ma D
Oncol Rep; 2006 May; 15(5):1147-52. PubMed ID: 16596177
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia Created Human Mesenchymal Stem Cell Sheet for Prevascularized 3D Tissue Construction.
Zhang L; Xing Q; Qian Z; Tahtinen M; Zhang Z; Shearier E; Qi S; Zhao F
Adv Healthc Mater; 2016 Feb; 5(3):342-52. PubMed ID: 26663707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
